SARAJEVO (Bosnia and Herzegovina), January 31 (SeeNews) â Luxembourg-based Haden has lowered by 30% the ask price of its 15.95% stake in Bosnian drug maker Bosnalijek [SAJ:BSNLR] it is attempting to sell on the Sarajevo Stock Exchange (SASE), bourse data showed.